Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 33-37, January 2010

Nephropathic complication of type-2 diabetes is following pattern of autoimmune diseases?

  • Mohammad Kazemi Arababadi

      Affiliations

    • Dept. of Microbiology, Hematology and Immunology, Faculty of Medicine, Rafsanjan University of Medical Science, Rafsanjan, Iran
    • Corresponding Author InformationCorresponding author at: Dept. of Microbiology and Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Tel.: +98 3915234003–5; fax: +98 3915225209.
  • ,
  • Reza Nosratabadi

      Affiliations

    • Dept. of Laboratory Sciences, Faculty of Medicine, Islamic Azad University, Zahedan Branch, Zahedan, Iran
  • ,
  • Gholamhossein Hassanshahi

      Affiliations

    • Dept. of Microbiology, Hematology and Immunology, Faculty of Medicine, Rafsanjan University of Medical Science, Rafsanjan, Iran
  • ,
  • Narges Yaghini

      Affiliations

    • Dept. of Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Science, Rafsanjan, Iran
  • ,
  • Vahid Pooladvand

      Affiliations

    • Dept. of Biochemistry, Faculty of Medicine, Rafsanjan University of Medical Science, Rafsanjan, Iran
  • ,
  • Ali Shamsizadeh

      Affiliations

    • Dept. of Physiology, Faculty of Medicine, Rafsanjan University of Medical Science, Rafsanjan, Iran
  • ,
  • Hamid Hakimi

      Affiliations

    • Dept. of Microbiology, Hematology and Immunology, Faculty of Medicine, Rafsanjan University of Medical Science, Rafsanjan, Iran
  • ,
  • Reza Derakhshan

      Affiliations

    • Ali-Ebne Abitaleb Hospital, Rafsanjan University of Medical Science, Rafsanjan, Iran

Received 2 May 2009; received in revised form 23 September 2009; accepted 28 September 2009. published online 30 October 2009.

Abstract 

The impact of several environmental and genetic factors on diabetes and its complications is well documented. The present study was aimed to examine the serum levels of IL-17A and IFN-γ as antagonistic cytokines in nephropathic and non-nephropathic type-2 diabetic patients. In this experimental study, serum samples were obtained from 180 type-2 diabetic patients, 100 nephropathic type-2 diabetic patients and 100 healthy controls. Serum levels of IL-17A and IFN-γ was detected by ELISA. Results of this study showed that the serum level of IFN-γ was higher in both diabetic patients (nephropathic and non-nephropathic) in comparison to the controls. In terms of IL-17A, while non-nephropathic type-2 diabetic patients showed an increased serum level of it, the other patients group had a lower serum level. Based on these findings, it can be concluded that the lower serum level of IL-17A is possibly associated with nephropathic complications of type-2 diabetes.

Keywords: IFN-γ, IL-17A, Diabetes, Nephropathy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(09)00419-7

doi:10.1016/j.diabres.2009.09.027

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 33-37, January 2010